| 000 | 01483 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513150149.0 | ||
| 264 | 0 | _c19980817 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm9801657 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuzuki, M | |
| 245 | 0 | 0 |
_aRational design of antitumor prostaglandins with high biological stability. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cJul 1998 |
||
| 300 |
_a3084-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xblood |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
| 650 | 0 | 4 |
_aCyclins _xbiosynthesis |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 |
_aG1 Phase _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProstaglandins _xblood |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aKiho, T | |
| 700 | 1 | _aTomokiyo, K | |
| 700 | 1 | _aFuruta, K | |
| 700 | 1 | _aFukushima, S | |
| 700 | 1 | _aTakeuchi, Y | |
| 700 | 1 | _aNakanishi, M | |
| 700 | 1 | _aNoyori, R | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 41 _gno. 16 _gp. 3084-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm9801657 _zAvailable from publisher's website |
| 999 |
_c9650975 _d9650975 |
||